Richards JM - Search Results

1

Sequential chemoimmunotherapy in the treatment of metastatic melanoma.

Richards JM, Mehta N, Ramming K, Skosey P. Richards JM, et al. J Clin Oncol. 1992 Aug;10(8):1338-43. doi: 10.1200/JCO.1992.10.8.1338. J Clin Oncol. 1992. PMID: 1634924 Clinical Trial.

2

Effective chemotherapy for melanoma after treatment with interleukin-2.

Richards JM, Gilewski TA, Ramming K, Mitchel B, Doane LL, Vogelzang NJ. Richards JM, et al. Cancer. 1992 Jan 15;69(2):427-9. doi: 10.1002/1097-0142(19920115)69:2<427::aid-cncr2820690225>3.0.co;2-0. Cancer. 1992. PMID: 1728371

3

Combination of chemotherapy with interleukin-2 and interferon alfa for the treatment of metastatic melanoma.

Richards JM, Gale D, Mehta N, Lestingi T. Richards JM, et al. J Clin Oncol. 1999 Feb;17(2):651-7. doi: 10.1200/JCO.1999.17.2.651. J Clin Oncol. 1999. PMID: 10080611 Clinical Trial.

4

Phase I study of weekly 24-hour infusions of recombinant human interleukin-2.

Richards JM, Barker E, Latta J, Ramming K, Vogelzang NJ. Richards JM, et al. J Natl Cancer Inst. 1988 Oct 19;80(16):1325-8. doi: 10.1093/jnci/80.16.1325. J Natl Cancer Inst. 1988. PMID: 3262771

5

Sequential chemoimmunotherapy for metastatic melanoma.

Richards JM. Richards JM. Semin Oncol. 1991 Oct;18(5 Suppl 7):91-5. Semin Oncol. 1991. PMID: 1948135

6

CI-980 in advanced melanoma and hormone refractory prostate cancer.

Ryan CW, Shulman KL, Richards JM, Kugler JW, Sosman JA, Ansari RH, Vokes EE, Vogelzang NJ. Ryan CW, et al. Among authors: richards jm. Invest New Drugs. 2000 May;18(2):187-91. doi: 10.1023/a:1006382014403. Invest New Drugs. 2000. PMID: 10857996 Clinical Trial.

7

Phase I study of adozelesin administered by 24-hour continuous intravenous infusion.

Fleming GF, Ratain MJ, O'Brien SM, Schilsky RL, Hoffman PC, Richards JM, Vogelzang NJ, Kasunic DA, Earhart RH. Fleming GF, et al. Among authors: richards jm. J Natl Cancer Inst. 1994 Mar 2;86(5):368-72. doi: 10.1093/jnci/86.5.368. J Natl Cancer Inst. 1994. PMID: 8308929 Clinical Trial.

8

Phase-I trial of Thiotepa, granulocyte-macrophage colony-stimulating factor and prednisone or pentoxifylline in patients with refractory solid tumors.

Devine S, Ratain M, Janisch L, Richards J, Williams S, Schilsky R, Vogelzang N, Skosey C. Devine S, et al. Oncol Rep. 1994 Jan;1(1):213-6. doi: 10.3892/or.1.1.213. Oncol Rep. 1994. PMID: 21607339

9

Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach.

Williams SF, Bitran JD, Richards JM, DeChristopher PJ, Barker E, Conant J, Golomb HM, Orlina AR. Williams SF, et al. Among authors: richards jm. Bone Marrow Transplant. 1990 Feb;5(2):129-33. Bone Marrow Transplant. 1990. PMID: 1968775

10

Biologic response modifiers in non-Hodgkin's lymphomas.

Gilewski TA, Richards JM. Gilewski TA, et al. Among authors: richards jm. Semin Oncol. 1990 Feb;17(1):74-87. Semin Oncol. 1990. PMID: 1689508 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page